254 related articles for article (PubMed ID: 1894172)
1. Prognostic factors for recurrence following negative second-look laparotomy in ovarian cancer patients treated with platinum-based chemotherapy.
Rubin SC; Hoskins WJ; Saigo PE; Chapman D; Hakes TB; Markman M; Reichman B; Almadrones L; Lewis JL
Gynecol Oncol; 1991 Aug; 42(2):137-41. PubMed ID: 1894172
[TBL] [Abstract][Full Text] [Related]
2. Recurrence after negative second-look laparotomy for ovarian cancer: analysis of risk factors.
Rubin SC; Hoskins WJ; Hakes TB; Markman M; Cain JM; Lewis JL
Am J Obstet Gynecol; 1988 Nov; 159(5):1094-8. PubMed ID: 3189442
[TBL] [Abstract][Full Text] [Related]
3. Ten-year follow-up of ovarian cancer patients after second-look laparotomy with negative findings.
Rubin SC; Randall TC; Armstrong KA; Chi DS; Hoskins WJ
Obstet Gynecol; 1999 Jan; 93(1):21-4. PubMed ID: 9916949
[TBL] [Abstract][Full Text] [Related]
4. Second-look laparotomy in stage I ovarian cancer following comprehensive surgical staging.
Rubin SC; Jones WB; Curtin JP; Barakat RR; Hakes TB; Hoskins WJ
Obstet Gynecol; 1993 Jul; 82(1):139-42. PubMed ID: 8515914
[TBL] [Abstract][Full Text] [Related]
5. Second-look laparotomy in stage III epithelial ovarian cancer: clinical variables associated with disease status.
Berek JS; Hacker NF; Lagasse LD; Poth T; Resnick B; Nieberg RK
Obstet Gynecol; 1984 Aug; 64(2):207-12. PubMed ID: 6539884
[TBL] [Abstract][Full Text] [Related]
6. A review of second-look laparotomy for ovarian cancer.
Cain JM; Saigo PE; Pierce VK; Clark DG; Jones WB; Smith DH; Hakes TB; Ochoa M; Lewis JL
Gynecol Oncol; 1986 Jan; 23(1):14-25. PubMed ID: 3943748
[TBL] [Abstract][Full Text] [Related]
7. [Follow-up of 70 patients with advanced ovarian cancer after negative second-look laparotomy].
Kojs Z; Glinski B; Pudelek J; Urbanski K; Karolewski K; Mitus J; Reinfuss M
J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1):16-22. PubMed ID: 16446607
[TBL] [Abstract][Full Text] [Related]
8. Second-look laparotomy after modified posterior exenteration: patterns of persistence and recurrence in patients with stage III and stage IV ovarian cancer.
Spirtos NM; Eisenkop SM; Schlaerth JB; Ballon SC
Am J Obstet Gynecol; 2000 Jun; 182(6):1321-7. PubMed ID: 10871445
[TBL] [Abstract][Full Text] [Related]
9. Cytoreductive surgery in ovarian carcinoma patients with a documented previously complete surgical response.
Vaccarello L; Rubin SC; Vlamis V; Wong G; Jones WB; Lewis JL; Hoskins WJ
Gynecol Oncol; 1995 Apr; 57(1):61-5. PubMed ID: 7705701
[TBL] [Abstract][Full Text] [Related]
10. Long-term results of a cisplatin-containing combination chemotherapy regimen for the treatment of advanced ovarian carcinoma.
Louie KG; Ozols RF; Myers CE; Ostchega Y; Jenkins J; Howser D; Young RC
J Clin Oncol; 1986 Nov; 4(11):1579-85. PubMed ID: 3095501
[TBL] [Abstract][Full Text] [Related]
11. Second line platinum-based intraperitoneal chemotherapy for advanced ovarian cancer.
Milczek T; Klasa-Mazurkiewicz D; Emerich J; Kobierski J
Acta Obstet Gynecol Scand; 2009; 88(4):463-7. PubMed ID: 19235559
[TBL] [Abstract][Full Text] [Related]
12. Long-term survival of 106 stage III ovarian cancer patients with minimal residual disease after second-look laparotomy and consolidation radiotherapy.
Petit T; Velten M; d'Hombres A; Marchal C; Montbarbon X; Mornex F; Quetin P; Gérard JP; Romestaing P; Carrie C
Gynecol Oncol; 2007 Jan; 104(1):104-8. PubMed ID: 16987544
[TBL] [Abstract][Full Text] [Related]
13. Long-term prognosis following macroscopic complete response at second-look laparotomy in advanced ovarian cancer patients treated with platinum-based chemotherapy. The Gruppo Oncologico Nord Ovest.
Chiara S; Lionetto R; Campora E; Oliva C; Merlini L; Bruzzi P; Rosso R; Conte PF
Eur J Cancer; 1995; 31A(3):296-301. PubMed ID: 7786592
[TBL] [Abstract][Full Text] [Related]
14. Platinum-based chemotherapy of high-risk stage I epithelial ovarian cancer following comprehensive surgical staging.
Rubin SC; Wong GY; Curtin JP; Barakat RR; Hakes TB; Hoskins WJ
Obstet Gynecol; 1993 Jul; 82(1):143-7. PubMed ID: 8515915
[TBL] [Abstract][Full Text] [Related]
15. Intraperitoneal cisplatin chemotherapy versus abdominopelvic irradiation in ovarian carcinoma patients after second-look laparotomy.
Menczer J; Ben-Baruch G; Modan M; Brenner H
Cancer; 1989 Apr; 63(8):1509-13. PubMed ID: 2924259
[TBL] [Abstract][Full Text] [Related]
16. Second-look laparotomy for ovarian cancer provides reliable prognostic information and improves survival.
Friedman RL; Eisenkop SM; Wang HJ
Gynecol Oncol; 1997 Oct; 67(1):88-94. PubMed ID: 9345362
[TBL] [Abstract][Full Text] [Related]
17. [Patients with advanced ovarian cancer after negative second-look laparoscopy--follow up study].
Pudełek J; Kojs Z; Urbański K; Mituś J; Reinfuss M; Klimek M
Ginekol Pol; 2004 Feb; 75(2):85-90. PubMed ID: 15108578
[TBL] [Abstract][Full Text] [Related]
18. Advanced ovarian cancer patients with no evidence of disease after platinum-based chemotherapy: retrospective analysis of the role of second-look.
Cacciari N; Zamagni C; Strocchi E; Pannuti F; Martoni A
Eur J Gynaecol Oncol; 1999; 20(1):56-60. PubMed ID: 10422684
[TBL] [Abstract][Full Text] [Related]
19. Consolidation intraperitoneal chemotherapy in epithelial ovarian cancer patients following negative second-look laparotomy.
Tarraza HM; Boyce CR; Smith WG; Jones MA
Gynecol Oncol; 1993 Sep; 50(3):287-90. PubMed ID: 8406188
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of second-look laparotomy for surgically confirmed early-stage epithelial ovarian cancer: a multicenter retrospective study.
Sato N; Akahira J; Kitamura T; Aoki M; Yoshinaga K; Okamura C; Utsunomiya H; Shimizu T; Niikura H; Ito K; Okamura K; Yaegashi N
Int J Clin Oncol; 2003 Feb; 8(1):40-4. PubMed ID: 12601541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
